4 active not recruiting, 3 recruiting, 2 unknown, 1 not yet recruiting. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow HCM - Hypertrophic Cardiomyopathy: new trials by email Literature Review of HCM - Hypertrophic Cardiomyopathy trials Research Report on HCM - Hypertrophic Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR Henagliflozin (SGLT2 Inhibitor), Placebo - HCM - Hypertrophic Cardiomyopathy | Not applicable | Not yet recruiting | Shanghai East Hospital | 150 | 2026-01-07 | 2025-12-19 |
| Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy ICD with left bundle branch area pacing (LBBAP), dual-chamber ICD - HCM - Hypertrophic Cardiomyopathy, Sudden Cardiac Death | Not applicable | Recruiting | Meshalkin Research Institute of Pathology of Circulation | 30 | 2025-11-14 | 2026-01-28 |
| Automated Reports Generation of Cardiovascular Magnetic Resonance Imaging large lanuage model - HCM - Hypertrophic Cardiomyopathy | Active not recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 20000 | 2025-10-01 | 2026-01-21 | |
| Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 250 | 2025-06-01 | 2026-02-02 | |
| Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy mavacamten - HCM - Hypertrophic Cardiomyopathy, Mavacamten | Not applicable | Active not recruiting | Xu Liu | 78 | 2025-04-20 | 2025-04-27 |
| An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death HCM - Hypertrophic Cardiomyopathy, S-ICD System (implantable Defibrillator) | Active not recruiting | China National Center for Cardiovascular Diseases | 589 | 2024-08-01 | 2024-09-19 | |
| Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions HCM - Hypertrophic Cardiomyopathy | Active not recruiting | Tampere University | 2500 | 2024-01-15 | 2026-08-17 | |
| Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score blood sampling (alpha-Galactosidase & LysoGb3) - Fabry Disease, Fabry Disease, Cardiac Variant | Not applicable | Unknown | Wuerzburg University Hospital | 200 | 2021-07-01 | 2024-06-12 |
| Observational Study for Patients With Hypertrophic Cardiomyopathy No intervention nor exposure - HCM - Hypertrophic Cardiomyopathy | Unknown | Guangdong Provincial People's Hospital | 500 | 2021-06-01 | 2021-04-20 | |
| DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies Non-ischemic Cardiomyopathy, DCM - Dilated Cardiomyopathy | Recruiting | University Hospital Heidelberg | 2040 | 2020-08-18 | 2023-11-30 |
Cardiomyopathy, Hypertrophic (10) · Fabry Disease (2) · Amyloid Neuropathies, Familial (1) · Amyloidosis (1) · Arrhythmogenic Right Ventricular Dysplasia (1) · Cardiomyopathies (1) · Cardiomyopathy, Dilated (1) · Death, Sudden, Cardiac (1) · Fabry Disease, Cardiac Variant (1) · Heart Failure (1) · Lysosomal Storage Diseases (1) · Rare Diseases (1)
Aortic Stenosis, Subvalvular (10) · Aortic Valve Disease (10) · Aortic Valve Stenosis (10) · Cardiovascular Diseases (10) · Heart Diseases (10) · Heart Valve Diseases (10) · Cardiomyopathies (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Brain Diseases (2) · Brain Diseases, Metabolic (2) · Brain Diseases, Metabolic, Inborn (2) · Central Nervous System Diseases (2)
Blood Specimen Collection (1) · Defibrillators, Implantable (1) · MYK-461 (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · henagliflozin (1)
China National Center for Cardiovascular Diseases (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Guangdong Provincial People's Hospital (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Meshalkin Research Institute of Pathology of Circulation (1) · Shanghai East Hospital (1) · Tampere University (1) · University Hospital Heidelberg (1) · Wuerzburg University Hospital (1) · Xu Liu (1)
China (5) · Germany (2) · Finland (1) · Italy (1) · Russia (1)
Cheng Huang, PhD (1) · Jari Hyttinen, Professor (1)